|
|
|
|
LEADER |
01121nam a22003377a 4500 |
001 |
00007676 |
003 |
AR-OvUNE |
005 |
20230308174303.0 |
006 |
a||||| 00| 0 |
007 |
ta |
008 |
141114n xxu||||| 00| 0 engd |
020 |
|
|
|a 9780849339721
|
040 |
|
|
|a AR-OvUNE
|c AR-OvUNE
|
080 |
0 |
|
|a 615.07
|b G616
|
100 |
1 |
|
|a Nally, Joseph D.
|e ed.
|9 4786
|
245 |
1 |
0 |
|a Good manufacturing practices for pharmaceuticals.
|
260 |
2 |
|
|b Informa Healthcare
|a New York
|c c2010
|
300 |
|
|
|a 398 p.
|c fig. byn. ; 26,5 cm
|
500 |
|
|
|a La información hace referencia a las últimas guías editadas por la FDA
|
650 |
|
4 |
|a BUENAS PRACTICAS DE MANUFACTURA
|9 8959
|
650 |
|
4 |
|a CONTROLES DE LABORATORIO
|9 9748
|
650 |
|
4 |
|a ENSAYOS CLINICOS
|
650 |
|
4 |
|a FARMACOLOGIA
|
650 |
|
4 |
|a GMP
|
650 |
|
7 |
|a INGREDIENTES FARMACEUTICOS ACTIVOS
|9 12467
|
650 |
|
4 |
|a INSPECCION DE MEDICAMENTOS
|9 12508
|
650 |
|
4 |
|a PRODUCCION DE MEDICAMENTOS
|
856 |
4 |
2 |
|u http://repositoriokoha.uner.edu.ar/fing/pdf/6263.pdf
|3 Indice
|
942 |
|
|
|c LIB
|2 udc
|
945 |
|
|
|c Registro migrado.
|a bcr
|b Nro. acceso original: 00007676
|
999 |
|
|
|c 5236
|d 5236
|